A PYMNTS Company
Antitrust Chronicle<sup>®</sup> – Healthcare

Antitrust Chronicle® – Healthcare

Spring 2020, Volume 2, Number 1

Dear Readers, In this Chronicle we turn to the timely issue of healthcare and competition. In light of the COVID-19 pandemic, the healthcare industry, in all its facets, including the development of pharmaceuticals, the provision of healthcare, and health insurance, has never been as vital. Antitrust rules have a key…

Read More

In this issue

Antitrust Chronicle® – Healthcare
CPI
May 11, 2020
Potential and Nascent Competition in FTC Merger Enforcement in Health Care Markets
Mike Moiseyev
May 11, 2020
Price Transparency: Friend or Foe? How Price Transparency May Impact Competition in the Health Care Industry
Dionne Lomax
May 11, 2020
Antitrust & COVID-19 in The U.S.: Four Key Issues for Healthcare Providers
John Carroll
May 11, 2020
Pay-For-Delay: Who Does the Generic Industry Lobby Represent?
Michael Carrier
May 11, 2020
Economic Tools for Analyzing Vertical Mergers in Healthcare
Josh Lustig
May 11, 2020
Non-Compete Agreements: Might They be Procompetitive in Healthcare?
Paul Wong
May 11, 2020
First of All, Do No Harm: New Directions in EU Antitrust Enforcement Regarding Pharmaceuticals
Ilan Akker
May 11, 2020
Rethinking Pharmaceutical Product Reformulations
Amalia Athanasiadou
May 11, 2020

In case you missed it...



October 2024


September 2024


August 2024
See more Chronicles by year:

Featured News

Japan’s Nippon Steel Eyes Year-End Close on $15B US Steel Deal Amid Political Uncertainty
Nov 7, 2024 by

Canada Orders Dissolution of TikTok’s Business Amid National Security Concerns
Nov 7, 2024 by

India Raids Amazon, Flipkart Seller Offices in Foreign Investment Probe
Nov 7, 2024 by

Canada’s Competition Bureau Seeks Public Feedback on Updated Merger Guidelines
Nov 7, 2024 by

FTC Adopts Stricter Reporting Rules for Mergers, Delays Expected in 2025
Nov 7, 2024 by